# Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection

> **NCT00655031** · PHASE2 · COMPLETED · sponsor: **POM Wonderful LLC** · enrollment: 150 (estimated)

## Conditions studied

- Common Cold

## Interventions

- **DIETARY_SUPPLEMENT:** Pomegranate Concentrate (POMx)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00655031
- **Lead sponsor:** POM Wonderful LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655031, "Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00655031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*